Skip to main content
Fig. 2 | BMC Ophthalmology

Fig. 2

From: Clinical safety and efficacy of vitamin D3 analog ointment for treatment of obstructive meibomian gland dysfunction

Fig. 2

Meibomian gland area for the same patient as in Fig. 1. Regions shown in green represent meibomian glands and dilated gland ducts as revealed by noninvasive meibography and analysis software. Meibomian gland area in the upper eyelid (upper two panels) was 11.9% before treatment, 12.4% after treatment for 4 weeks, and 36.3% after treatment for 8 weeks. The corresponding values for the lower eyelid (bottom two panels) were 16.6% before treatment, 15.8% after treatment for 4 weeks, and 26.5% after treatment for 8 weeks

Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us